Tuesday, August 08, 2006

Anti-miscarriage drug doubles breast cancer risk in daughters

The daughters of the thousands of women who took an anti-miscarriage pill more than 40 years ago are at increased risk of breast cancer, it was revealed yesterday. The drug, known as DES (diethylstilbestrol), was commonly prescribed for pregnant women between the 40s and 60s if doctors thought they were at risk of miscarrying and sometimes also for morning sickness. There are no definite figures for the number of women who took it, but research suggests there may have been as many as 200,000 in the UK. A study, published in the journal Cancer Epidemiology, Biomarkers and Prevention, has found that the daughters of women who took DES have almost double the risk of breast cancer of their peers and the more their mothers took, the greater their chance of developing the disease. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */